Canada markets closed

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6600+0.3300 (+24.81%)
At close: 04:00PM EST
1.6900 +0.03 (+1.81%)
After hours: 06:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close1.3300
Bid1.6400 x 1000
Ask1.7100 x 800
Day's Range1.4101 - 1.6700
52 Week Range0.8600 - 7.3500
Avg. Volume666,901
Market Cap109.689M
Beta (5Y Monthly)2.49
PE Ratio (TTM)N/A
EPS (TTM)-1.9700
Earnings DateFeb 21, 2024 - Feb 26, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.25

    Director Rowland Charles A Jr Acquires 342,960 Shares of Generation Bio Co (GBIO)

    In a notable insider transaction, Rowland Charles A Jr, a director at Generation Bio Co, has significantly increased his stake in the company.

  • GlobeNewswire

    Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

    Company to invest in highly selective cell-targeted lipid nanoparticle (ctLNP) delivery platform to develop wholly-owned programs for extrahepatic cell typesDevelopment of immune-quiet DNA (iqDNA) platform for lead hemophilia A program to continue Strategic reorganization will result in a 40% reduction of workforce Anticipated cost savings to extend cash runway into 2H 2027 CAMBRIDGE, Mass., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating ge

  • GlobeNewswire

    Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

    - Immune-quiet DNA evades innate immune sensors in both mice and non-human primates addressing a central challenge for non-viral DNA therapeutics - Proprietary cell-targeted LNP delivery system showed highly selective T cell transduction in humanized mouse model, demonstrating in vivo targeting for T cells and potentially for other extrahepatic tissues and cell types - Third quarter 2023 cash balance of $291.0 million expected to fund operations into 2026 CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE N